FR2422404A1 - Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation - Google Patents

Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation

Info

Publication number
FR2422404A1
FR2422404A1 FR7916099A FR7916099A FR2422404A1 FR 2422404 A1 FR2422404 A1 FR 2422404A1 FR 7916099 A FR7916099 A FR 7916099A FR 7916099 A FR7916099 A FR 7916099A FR 2422404 A1 FR2422404 A1 FR 2422404A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
benzylpyrimidine
diamino
preparation
sulfamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7916099A
Other languages
English (en)
Other versions
FR2422404B1 (fr
Inventor
Ivan Kompis
Alexander Eduard Wick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2422404A1 publication Critical patent/FR2422404A1/fr
Application granted granted Critical
Publication of FR2422404B1 publication Critical patent/FR2422404B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/08Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne des nouvelles compositions pharmaceutiques et leur préparation. Les compositions pharmaceutiques selon l'invention se caractérisent par le fait qu'elles contiennent : 1. Une 2,4-diamino-5-benzylpyrimidine de formule :
FR7916099A 1977-11-10 1979-06-22 Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation Granted FR2422404A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78487 1977-11-10
CH977678 1978-09-19

Publications (2)

Publication Number Publication Date
FR2422404A1 true FR2422404A1 (fr) 1979-11-09
FR2422404B1 FR2422404B1 (fr) 1983-02-04

Family

ID=25705315

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7831549A Granted FR2422647A1 (fr) 1977-11-10 1978-11-08 Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments
FR7916099A Granted FR2422404A1 (fr) 1977-11-10 1979-06-22 Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation
FR7916101A Granted FR2422648A1 (fr) 1977-11-10 1979-06-22 Nouvelles 2,4-diamino-5-benzyl-6-halogenopyrimidines
FR7916100A Granted FR2422632A1 (fr) 1977-11-10 1979-06-22 Nouveaux benzaldehydes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7831549A Granted FR2422647A1 (fr) 1977-11-10 1978-11-08 Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR7916101A Granted FR2422648A1 (fr) 1977-11-10 1979-06-22 Nouvelles 2,4-diamino-5-benzyl-6-halogenopyrimidines
FR7916100A Granted FR2422632A1 (fr) 1977-11-10 1979-06-22 Nouveaux benzaldehydes

Country Status (22)

Country Link
EP (3) EP0035624B1 (fr)
JP (1) JPS5476586A (fr)
AR (2) AR228423A1 (fr)
AT (1) AT359070B (fr)
AU (1) AU527943B2 (fr)
BR (1) BR7807425A (fr)
CA (1) CA1108611A (fr)
DE (1) DE2847825A1 (fr)
DK (1) DK144418C (fr)
ES (2) ES474921A1 (fr)
FI (1) FI783368A (fr)
FR (4) FR2422647A1 (fr)
GB (3) GB2007669B (fr)
GR (1) GR71725B (fr)
IL (1) IL55869A (fr)
IT (1) IT1100210B (fr)
MC (1) MC1222A1 (fr)
NL (1) NL7811170A (fr)
NO (1) NO783775L (fr)
PH (1) PH15918A (fr)
PT (1) PT68773A (fr)
SE (1) SE7811593L (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1138146B (it) * 1981-08-11 1986-09-17 Proter Spa Processo per la produzione della 2,4-diammino-(3,5-dimetossi-4-metos sietossi-benzil)-pirimidina
FR2516081B1 (fr) * 1981-11-09 1987-05-29 Wellcome Found Synthese de benzylpyrimidines et produits intermediaires pour cette synthese
DE3304202A1 (de) * 1983-02-08 1984-08-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von aromatischen aldehyden
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
PT99514B (pt) * 1990-11-14 1999-04-30 Chiron Corp Processo de preparacao de compostos para o tratamento de infeccoes fungicas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2165362A1 (de) * 1970-12-29 1972-07-27 Nisshin Flour Milling Co. Ltd., Tokio .-Verfahren zur Herstellung von Pyrimidinderivaten
NL7200058A (fr) * 1971-01-21 1972-07-25
IL38276A (en) * 1971-12-01 1976-09-30 Plantex Ltd Process for the preparation of 2,4-diamino-5-substituted benzylpyrimidines
BE798724A (fr) * 1973-04-26 1973-08-16 En Abrege Socechim Soc Et Chim Nouveaux composes chimiques
JPS6119628B2 (fr) * 1973-11-08 1986-05-17 Efu Hofuman Ra Roshu Unto Co Ag
CH605828A5 (fr) * 1974-12-24 1978-10-13 Hoffmann La Roche
DE2635765C3 (de) * 1976-08-09 1979-02-08 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von 2,4-EMamino-5-(3',4'r5'-trimethoxybenzyl)-pyrimidin

Also Published As

Publication number Publication date
DE2847825A1 (de) 1979-05-17
CA1108611A (fr) 1981-09-08
AU527943B2 (en) 1983-03-31
DK144418B (da) 1982-03-08
FR2422648B1 (fr) 1983-02-04
GB2007669B (en) 1982-10-20
NL7811170A (nl) 1979-05-14
GB2087378A (en) 1982-05-26
GB2086882A (en) 1982-05-19
JPS5476586A (en) 1979-06-19
DK144418C (da) 1982-08-09
EP0032395A1 (fr) 1981-07-22
ATA803378A (de) 1980-03-15
EP0035624A3 (en) 1981-09-23
FR2422632A1 (fr) 1979-11-09
GB2086882B (en) 1982-12-15
NO783775L (no) 1979-05-11
SE7811593L (sv) 1979-05-11
IL55869A (en) 1983-05-15
IL55869A0 (en) 1979-01-31
FR2422647A1 (fr) 1979-11-09
MC1222A1 (fr) 1979-07-20
EP0003212B1 (fr) 1982-03-17
DK500178A (da) 1979-05-11
BR7807425A (pt) 1979-07-24
AU4132378A (en) 1979-05-17
PT68773A (en) 1978-12-01
IT1100210B (it) 1985-09-28
GR71725B (fr) 1983-06-22
FR2422632B1 (fr) 1983-02-04
AT359070B (de) 1980-10-27
FR2422647B1 (fr) 1983-02-04
ES474921A1 (es) 1979-12-01
EP0035624B1 (fr) 1984-07-04
FI783368A (fi) 1979-05-11
PH15918A (en) 1983-04-22
FR2422404B1 (fr) 1983-02-04
GB2087378B (en) 1983-01-06
AR222831A1 (es) 1981-06-30
ES481038A1 (es) 1980-04-01
IT7829638A0 (it) 1978-11-09
EP0032395B1 (fr) 1983-03-23
EP0035624A2 (fr) 1981-09-16
FR2422648A1 (fr) 1979-11-09
EP0003212A1 (fr) 1979-08-08
GB2007669A (en) 1979-05-23
AR228423A1 (es) 1983-03-15

Similar Documents

Publication Publication Date Title
FR2446832A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
FR2400517A1 (fr) Triazolo-2,4-benzodiazepines et leur utilisation therapeutique
FR2293485A1 (fr) Compositions lubrifiantes ameliorees par l'addition de copolymeres greffes
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
FR2442836A1 (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique
FR2402473A1 (fr) Agents tensio-actifs constitues d'ethoxylats d'aminopropoxyalcanes
FR2422404A1 (fr) Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation
FR2431515A1 (fr) Composition de copolycarbonate-phenolphtaleine
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2388794A1 (fr) Isoindolines et leur preparation
FR2385707A1 (fr) 3-amino-6,7-dialcoxy-1h-1,2,4-benzothiadiazine-1-oxydes 1-substitues et leur utilisation comme medicaments
FR2453169A1 (fr) Composes de pyranone substitues en position 6 et leur utilisation comme produits pharmaceutiques
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
FR2446279A1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
FR2399248A2 (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
FR2359116A1 (fr) N-alkyldiphenylamines
FR2414513A1 (fr)
FR2401167A1 (fr) Derives de thienothiazine utiles comme medicaments
FR2395751A1 (fr) Compositions odoriferantes et/ou aromatisantes
FR2446833A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutiques
FR2442236A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse